DermTech Inc (DMTK)
0.6489
+0.02
(+3.44%)
USD |
NASDAQ |
May 07, 16:00
0.6489
0.00 (0.00%)
After-Hours: 20:00
DermTech Enterprise Value: -33.93M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 06, 2024 | -33.93M |
May 03, 2024 | -33.87M |
May 02, 2024 | -33.86M |
May 01, 2024 | -34.29M |
April 30, 2024 | -34.19M |
April 29, 2024 | -35.06M |
April 26, 2024 | -34.78M |
April 25, 2024 | -35.40M |
April 24, 2024 | -34.40M |
April 23, 2024 | -34.33M |
April 22, 2024 | -35.04M |
April 19, 2024 | -33.35M |
April 18, 2024 | -35.20M |
April 17, 2024 | -35.17M |
April 16, 2024 | -34.39M |
April 15, 2024 | -34.19M |
April 12, 2024 | -34.33M |
April 11, 2024 | -32.87M |
April 10, 2024 | -33.36M |
April 09, 2024 | -32.84M |
April 08, 2024 | -33.39M |
April 05, 2024 | -34.40M |
April 04, 2024 | -33.39M |
April 03, 2024 | -32.32M |
April 02, 2024 | -32.50M |
Date | Value |
---|---|
April 01, 2024 | -31.95M |
March 28, 2024 | -31.56M |
March 27, 2024 | -31.32M |
March 26, 2024 | -33.36M |
March 25, 2024 | -33.01M |
March 22, 2024 | -32.23M |
March 21, 2024 | -31.21M |
March 20, 2024 | -31.94M |
March 19, 2024 | -32.07M |
March 18, 2024 | -32.93M |
March 15, 2024 | -31.94M |
March 14, 2024 | -32.35M |
March 13, 2024 | -31.56M |
March 12, 2024 | -32.67M |
March 11, 2024 | -33.20M |
March 08, 2024 | -32.69M |
March 07, 2024 | -31.66M |
March 06, 2024 | -28.99M |
March 05, 2024 | -26.29M |
March 04, 2024 | -25.40M |
March 01, 2024 | -25.74M |
February 29, 2024 | -11.55M |
February 28, 2024 | -9.815M |
February 27, 2024 | -8.776M |
February 26, 2024 | -10.51M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-99.88M
Minimum
Dec 27 2022
1.964B
Maximum
Feb 19 2021
220.50M
Average
71.17M
Median
Dec 03 2019
Enterprise Value Benchmarks
RadNet Inc | 4.501B |
iSpecimen Inc | -2.496M |
23andMe Holding Co | -7.431M |
Sera Prognostics Inc | 272.58M |
Progyny Inc | 2.755B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -19.09M |
Revenue (Quarterly) | 3.924M |
Total Expenses (Quarterly) | 23.68M |
EPS Diluted (Quarterly) | -0.56 |
Gross Profit Margin (Quarterly) | 11.21% |
Profit Margin (Quarterly) | -486.5% |
Earnings Yield | -483.9% |
Normalized Earnings Yield | -483.92 |